Recursion Pharmaceuticals Inc vs Williams-Sonoma, Inc. — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while Williams-Sonoma, Inc. trades at $223.2 (market cap $26.30B). The key difference: Williams-Sonoma, Inc. is far larger — about 17.2× Recursion Pharmaceuticals Inc's market cap, and Williams-Sonoma, Inc. pays a 1.36% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | WSM | |
|---|---|---|
Market Cap | $1.53B | $26.30B |
Sector | Health | Consumer Cyclical |
52-Week High | $6.79 | $240.06 |
52-Week Low | $2.84 | $168.64 |
Enterprise Value | $946.50M | $27.14B |
Dividend Yield | — | 1.36% |
Trailing returns across standard periods
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →